Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 USD | +0.70% | -13.63% | -23.38% |
04-22 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
04-12 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.38% | 5.76M | |
+31.63% | 49.46B | |
+2.03% | 42.58B | |
+49.11% | 42.49B | |
-5.26% | 29.09B | |
+12.54% | 26.61B | |
-23.50% | 18.64B | |
+8.48% | 13.16B | |
+31.32% | 12.55B | |
+24.02% | 12.1B |
- Stock Market
- Equities
- ADIL Stock
- News Adial Pharmaceuticals, Inc.
- Adial Pharmaceuticals : Litchfield Hills Adjusts Price Target on Adial Pharmaceuticals to $15 From $5, Maintains Buy Rating